CD274 and trophoblastic neoplasm: Trophoblastic cells create a tolerogenic fetal-maternal interface by upregulating PD-L1 in syncytiotrophoblasts and intermediate trophoblasts, and trophoblastic tumors might also use PD-L1 expression to evade the host immune response, thereby promoting their survival (117).